ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
M&As this week: Alexion Pharmaceutical, OvaScience
americanpharmaceuticalreview
November 10, 2018Following the transaction,?Syntimmune will add its clinical-stage drug candidate SYNT001 to Alexion’s portfolio.SYNT001?is a humanised monoclonal antibody (mAb) that is currently being evaluated in Phase Ib/IIa studies. -
Millendo plans to go public through OvaScience takeover, in push to complete late-stage R&D
fiercebiotech
August 10, 2018Millendo Therapeutics plans to absorb the floundering, publicly traded fertility company OvaScience into its endocrine-based rare and orphan disease efforts.
Pharma Sources Insight January 2025
